Profile
Enrique Dilone is currently Director at La Casa de Don Pedro, Inc. and Chief Technology Officer at ImmunityBio, Inc. since 2023.
Formerly, Dr. Dilone was Executive Director-Quality & Analytics at NovaDel Pharma, Inc. from 2007 to 2009, Director-Analytical Operations at Oldtech, Inc. from 2002 to 2006, Senior Vice President-Technical Operations at Amicus Therapeutics, Inc. from 2009 to 2019, and Chief Technology Officer at Prothelia,.
Inc. Education includes undergraduate studies at New York University and graduate and doctorate degrees from Seton Hall University.
Enrique Dilone active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNITYBIO, INC. | Chief Tech/Sci/R&D Officer | 2023-08-13 |
La Casa de Don Pedro, Inc.
La Casa de Don Pedro, Inc. Miscellaneous Commercial ServicesCommercial Services Provides adult, alternative education, energy conservation, assistance and childhood programs | Director/Board Member | - |
Former positions of Enrique Dilone
| Companies | Position | End |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | 2019-09-30 |
| NOVADEL PHARMA INC | Corporate Officer/Principal | 2009-07-31 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2006-11-30 |
Prothelia, Inc.
Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Chief Tech/Sci/R&D Officer | - |
Training of Enrique Dilone
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
NovaDel Pharma, Inc.
NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops oral spray formulations | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Casa de Don Pedro, Inc.
La Casa de Don Pedro, Inc. Miscellaneous Commercial ServicesCommercial Services Provides adult, alternative education, energy conservation, assistance and childhood programs | Commercial Services |
Prothelia, Inc.
Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
ImmunityBio, Inc.
ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
- Stock Market
- Insiders
- Enrique Dilone
















